Buspar and Xanax are two anxiolytic medications most frequently administered for the management of anxiety. Buspar (buspirone) is medically approved by the U.S. FDA for the treatment of anxiety disorders (short-term and long-term) and acute anxiety – and Xanax (alprazolam) is medically approved by the U.S. FDA for the treatment of anxiety disorders and panic …
Ativan and Xanax are two of the most popular benzodiazepine medications commonly administered for the treatment of anxiety. Ativan is indicated (FDA approved) for the treatment of anxiety disorders, acute anxiety, and/or anxiety associated with depressive symptoms – and Xanax is indicated (FDA approved) for the treatment of anxiety disorders and panic disorder. D.J. Richards, …
Klonopin and Xanax are widely-utilized benzodiazepine medications for the management of panic disorder with or without agoraphobia. The medications differ in that Klonopin is approved by the FDA for the treatment of seizure disorders such as: Lennox-Gastaut syndrome, akinetic seizures, and myoclonic seizures (Xanax is not) – and Xanax is approved by the FDA for …
Valium and Xanax are two extremely popular benzodiazepine medications prescribed for the treatment of numerous medical conditions, most notably, generalized anxiety disorder and panic disorder. Occasionally, Xanax and Valium are prescribed on a short-term basis for the management of alcohol withdrawal or opioid detoxification. Of these two benzodiazepines, Valium is the “older” medication that hit …
Prozac and Zoloft are two common SSRI medications prescribed for the treatment of neuropsychiatric conditions, most notably, major depressive disorder (MDD). Prozac was developed by the pharmaceutical company Eli Lilly and went on to receive initial FDA approval in December 1987 as an antidepressant. Comparatively, Zoloft was developed by the pharmaceutical company Pfizer and went …
Fetzima (Levomilnacipran) is a medication prescribed for the treatment of major depressive disorder in adults. Although it is similar to the drug Savella (Milnacipran), Fetzima exhibits unique pharmacodynamics in that it functions as a serotonin-norepinephrine reuptake inhibitor (SNRI) with a 2-fold affinity for norepinephrine reuptake inhibition – relative to serotonin reuptake inhibition. In other words, …
Fetzima (Levomilnacipran), is a serotonin-norepinephrine reuptake inhibitor (SNRI) that was approved by the United States FDA in 2013 for the treatment of major depressive disorder. It was engineered to be a spinoff (or some might suggest an upgraded or slightly modified version) of the drug Savella (Milnacipran). Comparatively, Fetzima solely contains the levorotatory enantiomer of …